Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1082

1.

Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad.

Ghany MG, Feld JJ, Chang KM, Chan HLY, Lok ASF, Visvanathan K, Janssen HLA.

Lancet Gastroenterol Hepatol. 2020 Feb 10. pii: S2468-1253(19)30344-9. doi: 10.1016/S2468-1253(19)30344-9. [Epub ahead of print] Review.

PMID:
32057301
2.

Serum hepatitis B virus rna predicts response to peginterferon treatment in HBeAg-positive chronic hepatitis B.

van Campenhout MJH, van Bömmel F, Pfefferkorn M, Fischer J, Deichsel D, Boonstra A, van Vuuren AJ, Berg T, Hansen BE, Janssen HLA.

J Viral Hepat. 2020 Feb 12. doi: 10.1111/jvh.13272. [Epub ahead of print]

PMID:
32052503
3.

Evaluation of sustained virological response as a relevant surrogate endpoint for long-term outcomes of hepatitis C virus infection.

Krassenburg LAP, Zanjir WR, Georgie F, Stotland E, Janssen HLA, Hansen BE, Feld JJ.

Clin Infect Dis. 2020 Feb 13. pii: ciaa144. doi: 10.1093/cid/ciaa144. [Epub ahead of print]

PMID:
32052014
4.

IFN-α Suppresses Myeloid Cytokine Production, Impairing IL-12 Production and the Ability to Support T cell Proliferation.

Mehrotra A, D'Angelo JA, Romney-Vanterpool A, Chu T, Bertoletti A, Janssen HLA, Gehring AJ.

J Infect Dis. 2020 Feb 12. pii: jiaa064. doi: 10.1093/infdis/jiaa064. [Epub ahead of print]

PMID:
32049318
5.

Differential Leaflet Remodeling of Bone Marrow Cell Pre-Seeded Versus Nonseeded Bioresorbable Transcatheter Pulmonary Valve Replacements.

Fioretta ES, Lintas V, Mallone A, Motta SE, von Boehmer L, Dijkman PE, Cesarovic N, Caliskan E, Rodriguez Cetina Biefer H, Lipiski M, Sauer M, Putti M, Janssen HM, Söntjens SH, Smits AIPM, Bouten CVC, Emmert MY, Hoerstrup SP.

JACC Basic Transl Sci. 2019 Dec 11;5(1):15-31. doi: 10.1016/j.jacbts.2019.09.008. eCollection 2020 Jan.

6.

HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection.

Ferrando-Martinez S, Huang K, Bennett AS, Sterba P, Yu L, Suzich JA, Janssen HLA, Robbins SH.

JHEP Rep. 2019 Jun 28;1(3):170-178. doi: 10.1016/j.jhepr.2019.06.001. eCollection 2019 Sep.

7.

Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.

Papatheodoridis GV, Sypsa V, Dalekos GN, Yurdaydin C, Van Boemmel F, Buti M, Calleja JL, Chi H, Goulis J, Manolakopoulos S, Loglio A, Voulgaris T, Gatselis N, Keskin O, Veelken R, Lopez-Gomez M, Hansen BE, Savvidou S, Kourikou A, Vlachogiannakos J, Galanis K, Idilman R, Esteban R, Janssen H, Berg T, Lampertico P.

J Hepatol. 2020 Jan 22. pii: S0168-8278(20)30022-2. doi: 10.1016/j.jhep.2020.01.007. [Epub ahead of print]

PMID:
31981727
8.

Biodistribution, biocompatibility and targeted accumulation of magnetic nanoporous silica nanoparticles as drug carrier in orthopedics.

Janßen HC, Angrisani N, Kalies S, Hansmann F, Kietzmann M, Warwas DP, Behrens P, Reifenrath J.

J Nanobiotechnology. 2020 Jan 15;18(1):14. doi: 10.1186/s12951-020-0578-8.

9.

Hepatitis B virus RNA as Early Predictor for Response to PEGylated Interferon Alfa in HBeAg Negative Chronic Hepatitis B.

Farag MS, van Campenhout MJH, Pfefferkorn M, Fischer J, Deichsel D, Boonstra A, van Vuuren AJ, Ferenci P, Feld JJ, Berg T, Hansen BE, van Bömmel F, Janssen HLA.

Clin Infect Dis. 2020 Jan 8. pii: ciaa013. doi: 10.1093/cid/ciaa013. [Epub ahead of print]

PMID:
31912157
10.

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis.

Harms MH, de Veer RC, Lammers WJ, Corpechot C, Thorburn D, Janssen HLA, Lindor KD, Trivedi PJ, Hirschfield GM, Pares A, Floreani A, Mayo MJ, Invernizzi P, Battezzati PM, Nevens F, Ponsioen CY, Mason AL, Kowdley KV, Hansen BE, Buuren HRV, van der Meer AJ.

Gut. 2019 Dec 16. pii: gutjnl-2019-319057. doi: 10.1136/gutjnl-2019-319057. [Epub ahead of print]

11.

Liver safety assessment in clinical trials of new agents for chronic hepatitis B.

Fontana RJ, Avigan MI, Janssen HLA, Regev A, Mishra P, Gaggar A, Brown N, Wat C, Mendez P, Anderson RT, Given B, Miller V, Beumont M.

J Viral Hepat. 2020 Feb;27(2):96-109. doi: 10.1111/jvh.13223. Epub 2019 Dec 11. Review.

PMID:
31828894
12.

Risk of gallbladder cancer in patients with primary sclerosing cholangitis and radiographically detected gallbladder polyps.

van Erp LW, Cunningham M, Narasimman M, Ale Ali H, Jhaveri K, Drenth JPH, Janssen HLA, Levy C, Hirschfield GM, Hansen BE, Gulamhusein AF.

Liver Int. 2020 Feb;40(2):382-392. doi: 10.1111/liv.14326. Epub 2019 Dec 20.

PMID:
31823479
13.

Challenges with stopping long-term nucleos(t)ide analogue therapy in patients with chronic hepatitis B.

Liem KS, Gehring AJ, Feld JJ, Janssen HLA.

Gastroenterology. 2019 Dec 3. pii: S0016-5085(19)41872-6. doi: 10.1053/j.gastro.2019.10.050. [Epub ahead of print] No abstract available.

PMID:
31809724
14.

Supercritical fluid chromatography as a rapid single-step method for the determination of mineral oil saturated and aromatic hydrocarbons in purified mineral oils for food and cosmetics applications.

García-Cicourel AR, van de Velde B, Roskam G, Janssen HG.

J Chromatogr A. 2019 Nov 15:460713. doi: 10.1016/j.chroma.2019.460713. [Epub ahead of print]

15.

Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.

Aarts CEM, Hiemstra IH, Béguin EP, Hoogendijk AJ, Bouchmal S, van Houdt M, Tool ATJ, Mul E, Jansen MH, Janssen H, van Alphen FPJ, de Boer JP, Zuur CL, Meijer AB, van den Berg TK, Kuijpers TW.

Blood Adv. 2019 Nov 26;3(22):3562-3574. doi: 10.1182/bloodadvances.2019031609.

16.

M2-polarized tumor-associated macrophages promote epithelial-mesenchymal transition via activation of the AKT3/PRAS40 signaling pathway in intrahepatic cholangiocarcinoma.

Sun D, Luo T, Dong P, Zhang N, Chen J, Zhang S, Dong L, Janssen HLA, Zhang S.

J Cell Biochem. 2019 Nov 6. doi: 10.1002/jcb.29514. [Epub ahead of print]

PMID:
31692069
17.

Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia.

Zhou K, Wahed AS, Cooper S, Di Bisceglie AM, Fontana RJ, Ghany MG, Khalili M, Lok AS, Perrillo R, Lee WM, Lau DTY, Sterling R, Janssen HLA, Terrault NA.

Am J Gastroenterol. 2019 Nov;114(11):1753-1763. doi: 10.14309/ajg.0000000000000400.

PMID:
31658127
18.

Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV Network.

Coffin CS, Ramji A, Cooper CL, Miles D, Doucette KE, Wong P, Tam E, Wong DK, Wong A, Ukabam S, Bailey RJ, Tsoi K, Conway B, Barrett L, Michalak TI, Congly SE, Minuk G, Kaita K, Kelly E, Ko HH, Janssen HLA, Uhanova J, Lethebe BC, Haylock-Jacobs S, Ma MM, Osiowy C, Fung SK; Canadian HBV Network.

CMAJ Open. 2019 Oct 22;7(4):E610-E617. doi: 10.9778/cmajo.20190103. Print 2019 Oct-Dec. Erratum in: CMAJ Open. 2019 Dec 3;7(4):E699.

19.

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response.

Murillo Perez CF, Hirschfield GM, Corpechot C, Floreani A, Mayo MJ, van der Meer A, Ponsioen CY, Lammers WJ, Parés A, Invernizzi P, Carbone M, Maria Battezzati P, Nevens F, Kowdley KV, Thorburn D, Mason AL, Trivedi PJ, Lindor KD, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Janssen HLA, Hansen BE, Gulamhusein A; GLOBAL PBC Study Group.

Aliment Pharmacol Ther. 2019 Nov;50(10):1127-1136. doi: 10.1111/apt.15533. Epub 2019 Oct 17.

PMID:
31621931
20.

Management of insomnia in sleep disordered breathing.

Janssen HCJP, Venekamp LN, Peeters GAM, Pijpers A, Pevernagie DAA.

Eur Respir Rev. 2019 Oct 9;28(153). pii: 190080. doi: 10.1183/16000617.0080-2019. Print 2019 Sep 30. Review.

21.

Reply.

Choi HSJ, Brouwer WP, Hansen BE, Janssen HLA, Patel K.

Hepatology. 2020 Feb;71(2):769. doi: 10.1002/hep.30980. Epub 2020 Jan 28. No abstract available.

PMID:
31593309
22.

Remote vitals monitoring in rodents using video recordings.

Kunczik J, Barbosa Pereira C, Zieglowski L, Tolba R, Wassermann L, Häger C, Bleich A, Janssen H, Thum T, Czaplik M.

Biomed Opt Express. 2019 Aug 5;10(9):4422-4436. doi: 10.1364/BOE.10.004422. eCollection 2019 Sep 1.

23.

A new species of Lycodon Boie, 1826 (Serpentes, Colubridae) from northern Vietnam.

Janssen HY, Pham CT, Ngo HT, Le MD, Nguyen TQ, Ziegler T.

Zookeys. 2019 Sep 10;875:1-29. doi: 10.3897/zookeys.875.35933. eCollection 2019.

24.

CAPS1 Suppresses Tumorigenesis in Cholangiocarcinoma.

Weng S, Janssen HLA, Zhang N, Tang W, Bai E, Yang B, Dong L.

Dig Dis Sci. 2019 Sep 27. doi: 10.1007/s10620-019-05843-9. [Epub ahead of print]

PMID:
31562609
25.

Frontline Science: Low regulatory T cells predict perioperative major adverse cardiovascular and cerebrovascular events after noncardiac surgery.

Scholz AS, Handke J, Gillmann HJ, Zhang Q, Dehne S, Janssen H, Arens C, Espeter F, Sander A, Giannitsis E, Uhle F, Weigand MA, Motsch J, Larmann J.

J Leukoc Biol. 2019 Sep 15. doi: 10.1002/JLB.5HI1018-392RR. [Epub ahead of print]

PMID:
31523852
26.

Hepatitis C Core-Antigen Testing from Dried Blood Spots.

Biondi MJ, van Tilborg M, Smookler D, Heymann G, Aquino A, Perusini S, Mandel E, Kozak RA, Cherepanov V, Kowgier M, Hansen B, Goneau LW, Janssen HLA, Mazzulli T, Cloherty G, de Knegt RJ, Feld JJ.

Viruses. 2019 Sep 6;11(9). pii: E830. doi: 10.3390/v11090830.

27.

Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinoma.

Zhu HR, Yu XN, Zhang GC, Shi X, Bilegsaikhan E, Guo HY, Liu LL, Cai Y, Song GQ, Liu TT, Dong L, Janssen HLA, Weng SQ, Wu J, Shen XZ, Zhu JM.

Int J Mol Med. 2019 Nov;44(5):1844-1854. doi: 10.3892/ijmm.2019.4323. Epub 2019 Aug 23.

28.

Integrated impedance bridge for absolute capacitance measurements at cryogenic temperatures and finite magnetic fields.

Verbiest GJ, Janssen H, Xu D, Ge X, Goldsche M, Sonntag J, Khodkov T, Banszerus L, von den Driesch N, Buca D, Watanabe K, Taniguchi T, Stampfer C.

Rev Sci Instrum. 2019 Aug;90(8):084706. doi: 10.1063/1.5089207.

PMID:
31472650
29.

Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study).

Liem KS, Fung S, Wong DK, Yim C, Noureldin S, Chen J, Feld JJ, Hansen BE, Janssen HLA.

Gut. 2019 Dec;68(12):2206-2213. doi: 10.1136/gutjnl-2019-318981. Epub 2019 Aug 28.

PMID:
31462554
30.

Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials.

Wong WWL, Pechivanoglou P, Wong J, Bielecki JM, Haines A, Erman A, Saeed Y, Phoon A, Tadrous M, Younis M, Rayad NZ, Rac V, Janssen HLA, Krahn MD.

Syst Rev. 2019 Aug 19;8(1):207. doi: 10.1186/s13643-019-1126-1.

31.

Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis.

Gatselis NK, Goet JC, Zachou K, Lammers WJ, Janssen HLA, Hirschfield G, Corpechot C, Lindor KD, Invernizzi P, Mayo MJ, Battezzati PM, Floreani A, Pares A, Lygoura V, Nevens F, Mason AL, Kowdley KV, Ponsioen CY, Bruns T, Thorburn D, Verhelst X, Harms MH, van Buuren HR, Hansen BE, Dalekos GN; Global Primary Biliary Cholangitis Study Group.

Clin Gastroenterol Hepatol. 2020 Mar;18(3):684-692.e6. doi: 10.1016/j.cgh.2019.08.013. Epub 2019 Aug 13.

PMID:
31419573
32.

Idiopathic Noncirrhotic Portal Hypertension.

Janssen HLA.

Gastroenterol Hepatol (N Y). 2019 Jul;15(7):393-395. No abstract available.

33.

Distinguishing drug isomers in the forensic laboratory: GC-VUV in addition to GC-MS for orthogonal selectivity and the use of library match scores as a new source of information.

Kranenburg RF, García-Cicourel AR, Kukurin C, Janssen HG, Schoenmakers PJ, van Asten AC.

Forensic Sci Int. 2019 Sep;302:109900. doi: 10.1016/j.forsciint.2019.109900. Epub 2019 Jul 26.

PMID:
31382222
34.

Comprehensive off-line silver phase liquid chromatography × gas chromatography with flame ionization and vacuum ultraviolet detection for the detailed characterization of mineral oil aromatic hydrocarbons.

García-Cicourel AR, van de Velde B, Verduin J, Janssen HG.

J Chromatogr A. 2019 Dec 6;1607:460391. doi: 10.1016/j.chroma.2019.460391. Epub 2019 Jul 23.

35.

Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion.

Van Hees S, Chi H, Hansen B, Bourgeois S, Van Vlierberghe H, Sersté T, Francque S, Wong D, Sprengers D, Moreno C, Nevens F, Janssen H, Vanwolleghem T.

Viruses. 2019 Jul 26;11(8). pii: E687. doi: 10.3390/v11080687.

36.

Patient readiness for risk-reduction education and lifestyle change following transient ischemic attack.

Geldens N, Crowfoot G, Sweetapple A, Vyslysel G, Mason G, English C, Janssen H.

Disabil Rehabil. 2019 Jul 25:1-6. doi: 10.1080/09638288.2019.1626918. [Epub ahead of print]

PMID:
31343931
37.

The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review.

Batalla A, Janssen H, Gangadin SS, Bossong MG.

J Clin Med. 2019 Jul 19;8(7). pii: E1058. doi: 10.3390/jcm8071058. Review.

38.

Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B.

Choi HSJ, Brouwer WP, Zanjir WMR, de Man RA, Feld JJ, Hansen BE, Janssen HLA, Patel K.

Hepatology. 2020 Feb;71(2):539-548. doi: 10.1002/hep.30857. Epub 2019 Oct 17.

PMID:
31309589
39.

Acute thromboses and occlusions of dual layer carotid stents in endovascular treatment of tandem occlusions.

Pfaff JAR, Maurer C, Broussalis E, Janssen H, Blanc R, Dargazanli C, Costalat V, Piotin M, Runck F, Berlis A, Killer-Oberpfalzer M, Hensler JT, Bendszus M, Wodarg F, Möhlenbruch MA.

J Neurointerv Surg. 2020 Jan;12(1):33-37. doi: 10.1136/neurintsurg-2019-015032. Epub 2019 Jul 15.

PMID:
31308199
40.

New-generation positional therapy in patients with positional central sleep apnea.

Benoist LBL, Vonk PE, de Vries N, Janssen HCJP, Verbraecken J.

Eur Arch Otorhinolaryngol. 2019 Sep;276(9):2611-2619. doi: 10.1007/s00405-019-05545-y. Epub 2019 Jul 13.

PMID:
31302742
41.

Methods for one- and two-dimensional gas chromatography with flame ionization detection for identification of Mycobacterium tuberculosis in sputum.

Arslan FN, Kolk A, Janssen HG.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Aug 15;1124:204-217. doi: 10.1016/j.jchromb.2019.06.012. Epub 2019 Jun 8.

PMID:
31229913
42.

Immunocrit, serum amino acid concentrations and growth performance in light and heavy piglets depending on sow's farrowing system.

Schnier S, Middendorf L, Janssen H, Brüning C, Rohn K, Visscher C.

Porcine Health Manag. 2019 Jun 14;5:14. doi: 10.1186/s40813-019-0121-1. eCollection 2019.

43.

Reply.

Brahmania M, Janssen HLA.

Clin Gastroenterol Hepatol. 2020 Jan;18(1):267-268. doi: 10.1016/j.cgh.2019.06.019. Epub 2019 Jun 17. No abstract available.

PMID:
31220644
44.

[Perioperative cardiovasular morbidity and mortality in noncardiac surgical interventions : Measures for optimal anesthesiological care].

Janßen H, Dehne S, Giannitsis E, Weigand MA, Larmann J.

Anaesthesist. 2019 Oct;68(10):653-664. doi: 10.1007/s00101-019-0616-9. Review. German.

PMID:
31201480
45.

What is the effect of interrupting prolonged sitting with frequent bouts of physical activity or standing on first or recurrent stroke risk factors? A scoping review.

Mackie P, Weerasekara I, Crowfoot G, Janssen H, Holliday E, Dunstan D, English C.

PLoS One. 2019 Jun 13;14(6):e0217981. doi: 10.1371/journal.pone.0217981. eCollection 2019. Review.

46.

Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication.

Younossi ZM, Stepanova M, Younossi I, Papatheodoridis G, Janssen HLA, Agarwal K, Nguyen MH, Gane E, Tsai N, Nader F.

Liver Int. 2019 Oct;39(10):1837-1844. doi: 10.1111/liv.14171. Epub 2019 Jul 2.

PMID:
31173468
47.

Prevalence and Impact of Hepatitis E Virus Infection Among Persons With Chronic Hepatitis B Living in the US and Canada.

McGivern DR, Lin HS, Wang J, Benzine T, Janssen HLA, Khalili M, Lisker-Melman M, Fontana RJ, Belle SH, Fried MW.

Open Forum Infect Dis. 2019 Apr 9;6(5):ofz175. doi: 10.1093/ofid/ofz175. eCollection 2019 May.

48.

Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B.

van Campenhout MJH, Rijckborst V, Brouwer WP, van Oord GW, Ferenci P, Tabak F, Akdogan M, Pinarbasi B, Simon K, de Knegt RJ, Boonstra A, Janssen HLA, Hansen BE.

J Viral Hepat. 2019 Oct;26(10):1156-1163. doi: 10.1111/jvh.13117. Epub 2019 Aug 4.

PMID:
31135084
49.

The degradation and performance of electrospun supramolecular vascular scaffolds examined upon in vitro enzymatic exposure.

van Haaften EE, Duijvelshoff R, Ippel BD, Söntjens SHM, van Houtem MHCJ, Janssen HM, Smits AIPM, Kurniawan NA, Dankers PYW, Bouten CVC.

Acta Biomater. 2019 Jul 1;92:48-59. doi: 10.1016/j.actbio.2019.05.037. Epub 2019 May 17.

PMID:
31108258
50.

Elevated Presepsin Is Associated With Perioperative Major Adverse Cardiovascular and Cerebrovascular Complications in Elevated-Risk Patients Undergoing Noncardiac Surgery: The Leukocytes and Cardiovascular Perioperative Events Study.

Handke J, Scholz AS, Gillmann HJ, Janssen H, Dehne S, Arens C, Kummer L, Uhle F, Weigand MA, Motsch J, Larmann J.

Anesth Analg. 2019 Jun;128(6):1344-1353. doi: 10.1213/ANE.0000000000003738.

PMID:
31094810

Supplemental Content

Loading ...
Support Center